NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Fractal Analytics Reports 8.5% Growth in Consolidated Profit After Tax

Fractal Analytics, a pure-play data and artificial intelligence (AI) company, reported an 8.5% growth in consolidated profit after tax to Rs 100 crore in the third quarter ended December 31, 2025.

The company's consolidated revenue from operations increased by 21% to Rs 854 crore during the reported quarter, up from Rs 707 crore in the same period a year ago. This growth was led by strong demand in the Healthcare and Life Sciences segment, which accounted for 20% of revenue and grew 78% year-over-year.

The Banking and Financial Services segment, which accounted for 12% of total revenue, grew by 26% year-over-year. Fractal Analytics shares rose nearly 7% on March 6 to Rs 811.05 apiece.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

As of March 31, 2025, the firm served global companies, including Microsoft, Apple, Nvidia, Alphabet, Amazon, Meta, and Tesla. The company's growth is attributed to its best-in-class organic growth, gross margins, and high client retention, reflecting the strength of its enterprise AI capabilities.

Key Highlights:

  • Consolidated profit after tax: Rs 100 crore (up 8.5% from Rs 92.2 crore in Q3 2024)
  • Consolidated revenue from operations: Rs 854 crore (up 21% from Rs 707 crore in Q3 2024)
  • Healthcare and Life Sciences segment growth: 78% year-over-year
  • Banking and Financial Services segment growth: 26% year-over-year

Investor Takeaway

Fractal Analytics' shares rose 7% after posting an 8.5% growth in Q3 net profit, indicating a positive trend in the company's performance.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.